Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Oligodendrocyte (pre-myelinating)
[{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458340/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458340/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458341/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458341/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458342/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458342/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458343/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458343/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458344/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458344/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458345/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458345/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458346/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458346/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458347/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458347/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458348/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458348/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458349/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458349/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845834a/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845834a/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845834b/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845834b/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845834c/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845834c/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845834d/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845834d/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845834e/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845834e/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845834f/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845834f/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458350/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458350/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458351/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458351/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458352/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458352/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458353/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458353/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458354/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458354/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458355/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458355/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458356/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458356/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458357/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458357/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458358/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458358/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458359/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458359/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845835a/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845835a/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845835b/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845835b/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845835c/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845835c/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845835d/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845835d/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845835e/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845835e/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845835f/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845835f/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458360/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458360/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458361/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458361/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458362/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458362/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458363/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458363/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458364/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458364/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458365/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458365/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458366/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458366/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458367/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458367/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458368/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458368/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458369/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458369/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845836a/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845836a/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845836b/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845836b/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845836c/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845836c/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845836d/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845836d/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845836e/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845836e/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba1845836f/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba1845836f/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458370/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458370/5a7cc6a90d495d001444bc2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e20227bbcd5bba18458371/5a7cc6a90d495d001444bc2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e20227bbcd5bba18458371/5a7cc6a90d495d001444bc2d.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
oligodendrocyte,oiigodendroglia,glial cell,myelin,myelination,neuron,neuroglia,pns,peripheral nervous system,axon,pre-myelinating oligodendrocyte,PMO
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
